The Effects of OMEGA-3 Fatty Acid Supplementation Upon Interleukin-12 and Interleukin-18 in Chronic Kidney Disease Patients
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 29 (5) , 377-385
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 65 references indexed in Scilit:
- The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney diseaseProstaglandins & Other Lipid Mediators, 2018
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease RisksJAMA Cardiology, 2018
- A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney diseaseClinical Nutrition, 2016
- Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapyFree Radical Biology and Medicine, 2014
- Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffnessCytokine, 2013
- Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis GraftsJAMA, 2012
- Effects of interleukin-18 on cardiac fibroblast function and gene expressionCytokine, 2011
- Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk menMetabolism, 2009
- C-reactive protein and n–3 fatty acids in patients with a previous myocardial infarctionEuropean Journal of Nutrition, 2007
- T helper cell related interleukins and the angiographic morphology in unstable anginaCytokine, 2005